跳至主要内容
临床试验/ISRCTN10623443
ISRCTN10623443进行中(未招募)未知

PROVE: PReeclampsia Obstetric adVerse Events

Stellenbosch University0 个研究点目标入组 300 人开始时间: 2020年7月16日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
300

研究概览

简要总结

2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33744176/ case control study (added 22/10/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/34392166/ observational study of blood pressure as a risk factor for eclampsia (added 22/10/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33492667/ observational study of cognitive impairment in preeclampsia (added 22/10/2021) 2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33924230/ protocol (added 22/10/2021) 2022 Other publications in https://doi.org/10.1161/jaha.121.024395 Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia (added 02/11/2023) 2022 Other publications in https://doi.org/10.1016/j.ajog.2022.03.009 Cardiac magnetic resonance imaging in preeclampsia complicated by pulmonary edema shows myocardial edema with normal left ventricular systolic function (added 02/11/2023) 2022 Other publications in https://doi.org/10.1016/j.ajog.2022.02.036 Cerebral biomarkers in neurologic complications of preeclampsia (added 02/11/2023) 2023 Other publications in https://doi.org/10.1210/endocr/bqad041 Circulating Chemerin Is Elevated in Women With Preeclampsia (added 02/11/2023) 2021 Other publications in https://doi.org/10.1161/jaha.120.020302 Circulating Growth Differentiation Factor 15 Is Increased Preceding Preeclampsia Diagnosis: Implications as a Disease Biomarker (added 02/11/2023) 2022 Other publications in https://doi.org/10.3389/fphys.2022.1022770 Circulating concentrations of glycocalyx degradation products in preeclampsia (added 02/11/2023) 2023 Other publications in https://doi.org/10.1016/j.preghy.2022.12.001 Correlation between cognitive assessment scores and circulating cerebral biomarkers in women with pre-eclampsia and eclampsia (added 02/11/2023) 2021 Other publications in https://doi.org/10.3390/cells10113045 Evidence of Neuroinflammation and Blood-Brain Barrier Disruption in Women with Preeclampsia and Eclampsia (added 02/11/2023) 2022 Other publications in https://doi.org/10.1161/jaha.121.024536 PSG7 and 9 (Pregnancy-Specific ß-1 Glycoproteins 7 and 9): Novel Biomarkers for Preeclampsia (added 02/11/2023)

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • 1.1. Women with a diagnosis of preeclampsia or severe preeclampsia in gestational week 20-42
  • 1.2. Admitted to Tygerberg hospital
  • Severe preeclampsia is defined as preeclampsia with an organ complication such as renal failure, pulmonary oedema, eclampsia, intracerebral hemorrhage, cerebral oedema, heart failure or disseminated intravascular coagulation
  • 2. Controls:
  • 2.1. Women with healthy pregnancies matched for gestational age admitted for delivery at Tygerberg hospital
  • Both primiparous and parous women are included

排除标准

  • 1. Cases: If the woman is not able to give informed consent
  • 1.1. For women with pulmonary edema: Existing cardiac disease
  • 1.2. For women with eclampsia: Existing neurological disease
  • 2. Normotensive controls:
  • 2.1. Pre-exisiting hypertension
  • 2.2. Diabetes mellitus before or during pregnancy
  • 2.3. Pre-exisiting cardiovascular, renal or cerebral disease
  • 2.4. Chronic medication

研究者

相似试验